All GLG News Analyses Filed Under: Oncology
Study of Breast Cancer Risk May Impact Myriad Genetics
Analysis of: Cancer-Gene Test Boosts Myriad's Sales | online.wsj.com
Author: Ken Powell, President Genesis Business Development
Analysis of: Novelos Therapeutics announces positive results in ongoing phase 2 neoadjuvant breast cancer trial as Musc Hollings Cancer Center | www.pipelinereview.com
Author: GLG Member Program Contributor
Posted May 13, 2008GSK: Gutsy but logical clinical trial of Tykerb v Herceptin (Genentech)
Analysis of: Glaxo Tests Tykerb vs Herceptin in Early Cancer | www.therapeuticsdaily.com
Author: Kenneth Algazy, Clinical Professor of Medicine University of Pennsylvania School of Medicine - CC
Posted May 12, 2008ImClone: Does Morgan Stanley (MS) know something we don't??
Analysis of: US Drug Stocks Edge Higher, But ImClone Falls On Downgrade | news.ino.com
Author: Kenneth Algazy, Clinical Professor of Medicine University of Pennsylvania School of Medicine - CC
Analysis of: Neutropenia: Biosimilar Product from India Moves One Step Closer to European Market | www.pipelinereview.com
Author: GLG Member Program Contributor
Posted May 9, 2008ASA404 approach in treating lung cancer
Analysis of: ASA404 begins pivotal trial to explore new approach in treating lung cancer, the leading cause of cancer death | www.pipelinereview.com
Author: Donald Fleming, Division Head of Hematology and Oncology MEDICAL CENTER OF VINCENNES
Analysis of: Proteolix Initiates Phase 2 Clinical Trial of Carfilzomib in Patients with Relapsed Solid Tumors | www.pipelinereview.com
Author: GLG Member Program Contributor
Analysis of: Oncothyreon files investigational new drug application for PX-866 oncology compound | www.pipelinereview.com
Author: GLG Member Program Contributor
Posted May 7, 2008Hedgehog pathwa drugs and chemotherapy
Analysis of: Curis Announces Genentech's Initiation of Hedgehog Antagonist Phase II Clinical Trial In Metastatic Colorectal Cancer | www.pipelinereview.com
Author: Donald Fleming, Division Head of Hematology and Oncology MEDICAL CENTER OF VINCENNES
Posted May 7, 2008Genomics are coming! Are we ready?
Analysis of: Cancer-Gene Test Boosts Myriad's Sales | online.wsj.com
Author: Kenneth Algazy, Clinical Professor of Medicine University of Pennsylvania School of Medicine - CC
More GLG News in
Healthcare
New Abbott Study of Investigational Vicodin CR(TM) Meets Primary Efficacy Endpoints in Phase III Trial
www.prnewswire.com
Abbott Scientists Present A New Approach for Treating Attention-Deficit Hyperactivity Disorder
biz.yahoo.com
FDA Approves Strattera® for Maintenance of ADHD in Children and Adolescents
newsroom.lilly.com
Speculators knock OPEC off oil-price perch
www.atimes.com
LASIK Worries? Some May See Better with Alternatives
www.washingtonpost.com
NNRs: A Novel direction?
May 12, 2008
LONG TERM ADIICTION CENTER MEDICAL DIRECTOR COMMENTS ON USE OF NARCOTIC ANALGESICS.
May 12, 2008
Analysis of Wal-Mart's Generics Plan
May 8, 2008
May be jumping into phase II too soon
May 7, 2008
Is LASIK the issue or is choosing the right refractive surgery for the right patient the real issue?
May 7, 2008

